XML 37 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY/(DEFICIT) - USD ($)
$ in Thousands
Ordinary shares
Cumulative effect, period of adoption, adjusted balance
Ordinary shares
Additional paid-in capital
Cumulative effect, period of adoption, adjusted balance
Additional paid-in capital
Treasury Stock
Cumulative effect, period of adoption, adjusted balance
Treasury Stock
Accumulated other comprehensive (loss) income
Cumulative effect, period of adoption, adjusted balance
Accumulated other comprehensive (loss) income
Accumulated deficit
Cumulative effect of accounting change
Accumulated deficit
Cumulative effect, period of adoption, adjusted balance
Accumulated deficit
Cumulative effect of accounting change
Cumulative effect, period of adoption, adjusted balance
Total
Beginning Balance at Dec. 31, 2020   $ 11   $ 27,315       $ 481     $ (192,474)     $ (164,667)
Beginning Balance (in shares) at Dec. 31, 2020   221,980,000                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of ordinary shares upon Initial Public Offering and related over-allotment option, net of cost of issuance   $ 2   904,730                   904,732
Issuance of ordinary shares upon Initial Public Offering and related over-allotment option, net of cost of issuance (in shares)   45,076,479                        
Issuance of ordinary shares prior to Initial Public Offering   $ 1   199,999                   200,000
Issuance of ordinary shares prior to Initial Public Offering (in shares)   16,026,282                        
Conversion of redeemable preferred shares   $ 14   333,653                   333,667
Conversion of redeemable preferred shares (in shares)   278,163,799                        
Issuance of ordinary shares reserved for equity incentive plan   $ 1       $ (1)                
Issuance of ordinary shares reserved for equity incentive plan (in shares)   10,000,000       (10,000,000)                
Repurchase of ordinary shares           $ (53,645)               (53,645)
Repurchase of ordinary shares (in share)           (7,008,269)                
Exercise of share option and vested restricted share unit       (5,646)   $ 6,716               1,070
Exercise of share option and vested restricted share unit (in shares)           5,403,461                
Net loss                     (175,424)     (175,424)
Fair value change of long-term investment               357           357
Foreign currency translation adjustment               1,482           1,482
Share-based compensation       66,089                   66,089
Ending Balance at Dec. 31, 2021   $ 29   1,526,140   $ (46,930)   2,320     (367,898)     1,113,661
Ending Balance (in shares) at Dec. 31, 2021   571,246,560                        
Ending Balance (in shares) at Dec. 31, 2021           (11,604,808)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Repurchase of ordinary shares           $ (59,631)               (59,631)
Repurchase of ordinary shares (in share)           (18,839,849)                
Exercise of share option and vested restricted share unit       (19,084)   $ 20,123               1,039
Exercise of share option and vested restricted share unit (in shares)           4,848,326                
Issuance of ordinary shares upon the Dual Primary Listing, net of cost of issuance       8,689                   8,689
Issuance of ordinary shares upon the Dual Primary Listing, net of cost of issuance (in shares)   7,300,000                        
Net loss                     (146,175)     (146,175)
Fair value change of long-term investment               (9,493)           (9,493)
Foreign currency translation adjustment               (14,942)           (14,942)
Share-based compensation       69,019                   69,019
Ending Balance at Dec. 31, 2022 $ 29 $ 29 $ 1,584,764 1,584,764 $ (86,438) $ (86,438) $ (22,115) (22,115) $ (460) $ (514,533) (514,073) $ (460) $ 961,707 $ 962,167
Ending Balance (in shares) at Dec. 31, 2022 578,546,560 578,546,560                        
Ending Balance (in shares) at Dec. 31, 2022         (25,596,331) (25,596,331)               25,596,331
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Repurchase of ordinary shares           $ (2,254)               $ (2,254)
Repurchase of ordinary shares (in share)           (1,200,794)                
Exercise of share option and vested restricted share unit       (27,361)   $ 28,548               1,187
Exercise of share option and vested restricted share unit (in shares)           6,047,833                
Cancellation of Treasury stock       (6,514)   $ 6,514                
Cancellation of Treasury stock (in shares)   (3,953,961)       3,953,961                
Net loss                     (60,315)     (60,315)
Fair value change of long-term investment               (7,791)           (7,791)
Transfer out of fair value changes of long-term investments               15,537           15,537
Foreign currency translation adjustment               (2,722)           (2,722)
Share-based compensation       65,216                   65,216
Ending Balance at Dec. 31, 2023   $ 29   $ 1,616,105   $ (53,630)   $ (17,091)     $ (574,848)     $ 970,565
Ending Balance (in shares) at Dec. 31, 2023   574,592,599                        
Ending Balance (in shares) at Dec. 31, 2023           (16,795,331)               16,795,331